541096 — Bharat Parenterals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹9.60bn
- IN₹11.42bn
- IN₹2.57bn
Annual cashflow statement for Bharat Parenterals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 328 | 271 | 279 | 235 | 187 |
| Depreciation | |||||
| Non-Cash Items | 3.5 | 43.4 | -18.1 | 29.2 | 63.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -246 | -130 | -338 | -107 | -387 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 145 | 244 | -10.7 | 217 | -47.1 |
| Capital Expenditures | -150 | -8.4 | -390 | -916 | -1,043 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 24.1 | -425 | 323 | 138 | -4.82 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -126 | -434 | -66.3 | -778 | -1,048 |
| Financing Cash Flow Items | -8.65 | -4.42 | 34.7 | 286 | 25.8 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -28.2 | 105 | 94.2 | 606 | 1,104 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.63 | -84.3 | 17.2 | 44.4 | 9.38 |